HRAS and skin squamous cell carcinoma: Additionally, another review has highlighted how mutations in TP53, NOTCH1, NOTCH2, CDKN2A, HRAS, and FAT1 are considered potential drivers of RDEB-cSCC tumorigenesis [29].